Actinium Pharmaceuticals
ATNM
ATNM
71 hedge funds and large institutions have $44.8M invested in Actinium Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 15 increasing their positions, 20 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
25% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 20
34% less call options, than puts
Call options by funds: $862K | Put options by funds: $1.31M
Holders
71
Holding in Top 10
–
Calls
$862K
Puts
$1.31M
Top Buyers
| 1 | +$8.54M | |
| 2 | +$2.86M | |
| 3 | +$2.14M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$1.3M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$765K |
Top Sellers
| 1 | -$2.19M | |
| 2 | -$1.32M | |
| 3 | -$844K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$703K |
| 5 |
HF
HRT Financial
New York
|
-$590K |